CARDIO DIAGNOSTICS HOLDINGS
CDIO · NASDAQ
Updated at 2026-10-14 09:34:49
- Today's High
- $1.86
- Today’s Low
- $1.75
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $1.90
- Previous Close
- $1.78
- Volume
- 61.62K
- Market Cap
- $5.26M
- P/E Ratio
- --
- EPS
- $-2.91
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 311 WEST SUPERIOR STREET, CHICAGO, IL, UNITED STATES, 60654
- Country
- US
- Listing Date
- 2021-11-23
- Fiscal Year End
- December
- Shares Outstanding
- 2.96M
- CIK
- 0001870144
- Website
- www.cardiodiagnosticsinc.com
Cardio Diagnostics Holdings Inc (CDIO) is a pioneering biotechnology firm focused on enhancing cardiovascular health through innovative diagnostic solutions. The company utilizes state-of-the-art technology to equip healthcare professionals with vital tools for precise assessment and management of cardiovascular diseases, thereby improving patient outcomes. With a commitment to personalized medicine and a robust growth strategy, CDIO stands out as an attractive investment opportunity for institutional investors seeking to capitalize on advancements in the dynamic healthcare sector.
Financial Metrics
Revenue
2026-06-30
$5.36K
2026-03-31
$2.68K
2025-12-31
$3.55K
2025-09-30
$2.85K
Operating Expenses
2026-06-30
$1.5M
2026-03-31
$1.69M
2025-12-31
$1.46M
2025-09-30
$1.71M
Net Income
2026-06-30
-$1.5M
2026-03-31
-$1.78M
2025-12-31
-$1.46M
2025-09-30
-$1.71M
Net Profit Margin
2026-06-30
-28.01K%
2026-03-31
-66.72K%
2025-12-31
-41.21K%
2025-09-30
-60.05K%
Earnings Per Share
2026-06-30
$-0.51
2026-03-31
$-0.62
2025-12-31
$-0.80
2025-09-30
$-0.98
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$1.4M
2026-03-31
-$1.69M
2025-12-31
-$1.36M
2025-09-30
-$1.62M
Effective Tax Rate
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $5.36K | $2.68K | $3.55K | $2.85K |
| Operating Expenses | $1.5M | $1.69M | $1.46M | $1.71M |
| Net Income | -$1.5M | -$1.78M | -$1.46M | -$1.71M |
| Net Profit Margin | -28.01K% | -66.72K% | -41.21K% | -60.05K% |
| Earnings Per Share | $-0.51 | $-0.62 | $-0.80 | $-0.98 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$1.4M | -$1.69M | -$1.36M | -$1.62M |
| Effective Tax Rate | -- | -- | -- | -- |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.